These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20805169)

  • 1. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008.
    Koshy E; Murray J; Bottle A; Sharland M; Saxena S
    Thorax; 2010 Sep; 65(9):770-4. PubMed ID: 20805169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England.
    Saxena S; Atchison C; Cecil E; Sharland M; Koshy E; Bottle A
    J Infect; 2015 Oct; 71(4):428-36. PubMed ID: 26159503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.
    Strachan RE; Snelling TL; Jaffé A
    Bull World Health Organ; 2013 Mar; 91(3):167-73. PubMed ID: 23476089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
    Grijalva CG; Nuorti JP; Arbogast PG; Martin SW; Edwards KM; Griffin MR
    Lancet; 2007 Apr; 369(9568):1179-86. PubMed ID: 17416262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
    Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
    Wiese AD; Griffin MR; Zhu Y; Mitchel EF; Grijalva CG
    Vaccine; 2016 Dec; 34(50):6243-6249. PubMed ID: 27832918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.
    Grijalva CG; Nuorti JP; Zhu Y; Griffin MR
    Clin Infect Dis; 2010 Mar; 50(6):805-13. PubMed ID: 20166818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study.
    Shiri T; McCarthy ND; Petrou S
    BMC Infect Dis; 2019 Jun; 19(1):510. PubMed ID: 31182036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.
    Scotta MC; Veras TN; Klein PC; Tronco V; Polack FP; Mattiello R; Pitrez PMC; Jones MH; Stein RT; Pinto LA
    Vaccine; 2014 Jul; 32(35):4495-4499. PubMed ID: 24958703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia.
    Strachan R; Homaira N; Beggs S; Bhuiyan MU; Gilbert GL; Lambert SB; Macartney K; Marshall H; Martin AC; McCallum GB; McCullagh A; McDonald T; McIntyre P; Oftadeh S; Ranganathan S; Suresh S; Wainwright CE; Wilson A; Wong M; Snelling T; Jaffé A
    Thorax; 2021 May; 76(5):487-493. PubMed ID: 33504566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis.
    Simonsen L; Taylor RJ; Schuck-Paim C; Lustig R; Haber M; Klugman KP
    Lancet Respir Med; 2014 May; 2(5):387-94. PubMed ID: 24815804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Oligbu G; Collins S; Andrews N; Sheppard CL; Fry NK; Slack MPE; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Oct; 65(7):1191-1198. PubMed ID: 29309553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study.
    Lau WCY; Bielicki J; Tersigni C; Saxena S; Wong ICK; Sharland M; Hsia Y
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):821-829. PubMed ID: 30993835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.